EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies

B Wang, Y Liu, Z Liao, H Wu, B Zhang… - … hematology & oncology, 2023 - Springer
Hepatocellular carcinoma (HCC) is the leading cause of cancer-related death. The
accumulation of genetic and epigenetic changes is closely related to the occurrence and …

Current updates of CRISPR/Cas9‐mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management

KS Allemailem, MA Alsahli, A Almatroudi… - Cancer …, 2022 - Wiley Online Library
Clustered regularly interspaced short palindromic repeats‐associated protein
(CRISPR/Cas9), an adaptive microbial immune system, has been exploited as a robust …

[HTML][HTML] Stromal-cell-derived factor (SDF) 1-alpha overexpression promotes bone regeneration by osteogenesis and angiogenesis in osteonecrosis of the femoral …

F Yang, F Xue, J Guan, Z Zhang, J Yin… - Cellular Physiology and …, 2018 - karger.com
Background/Aims: Osteonecrosis of the femoral head (ONFH) is a devastating orthopedic
disease. Previous studies suggested that stromal-cell-derived factor (SDF)-1 was involved in …

The role of glypican-3 in hepatocellular carcinoma: Insights into diagnosis and therapeutic potential

AR Devan, B Nair, GK Pradeep, R Alexander… - European Journal of …, 2024 - Springer
Abstract Glypican-3 (GPC-3) is predominantly found in the placenta and fetal liver, with
limited expression in adult tissues. Its re-expression in hepatocellular carcinoma (HCC) and …

The roles of cancer stem cell-derived secretory factors in sha** the immunosuppressive tumor microenvironment in hepatocellular carcinoma

GK Muliawan, TKW Lee - Frontiers in immunology, 2024 - frontiersin.org
Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies worldwide and
has a poor prognosis. Although immune checkpoint inhibitors have entered a new era of …

[HTML][HTML] CRISPR/Cas9 as a new antiviral strategy for treating hepatitis viral infections

UI Bartosh, AS Dome, NV Zhukova… - International Journal of …, 2023 - mdpi.com
Hepatitis is an inflammatory liver disease primarily caused by hepatitis A (HAV), B (HBV), C
(HCV), D (HDV), and E (HEV) viruses. The chronic forms of hepatitis resulting from HBV and …

[HTML][HTML] Understanding the inflammation-cancer transformation in the development of primary liver cancer

HJ Chen, MH Hu, FG Xu, HJ Xu, JJ She… - Hepatoma …, 2018 - oaepublish.com
Primary liver cancer is one of the leading causes of cancer-related deaths worldwide. China
has more than 55% liver cancer cases globally. The development of hepatocellular …

The CXCL12-CXCR4 signaling axis plays a key role in cancer metastasis and is a potential target for develo** novel therapeutics against metastatic cancer

P Yang, Y Hu, Q Zhou - Current medicinal chemistry, 2020 - ingentaconnect.com
Metastasis is the main cause of death in cancer patients; there is currently no effective
treatment for cancer metastasis. This is primarily due to our insufficient understanding of the …

Development of a chemoresistant risk scoring model for prechemotherapy osteosarcoma using single-cell sequencing

Z Zeng, W Li, D Zhang, C Zhang, X Jiang, R Guo… - Frontiers in …, 2022 - frontiersin.org
Background Chemoresistance is one of the leading causes that severely limits the success
of osteosarcoma treatment. Evaluating chemoresistance before chemotherapy poses a new …

CRISPR/Cas9-related technologies in liver diseases: from feasibility to future diversity

T Xu, L Li, Y Liu, W Cao, J Chen, S Hu… - International …, 2020 - pmc.ncbi.nlm.nih.gov
Liver diseases are one of the leading causes of mortality in the world, mainly caused by
different etiological agents, alcohol consumption, viruses, drug intoxication, and malnutrition …